Haemonetics | HAE - Equity Capital And Reserves


Haemonetics reported $849.17M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Avanos Medical USD 778M 1.7M Sep/2025
Baxter International USD 7.24B 79M Sep/2025
Becton, Dickinson and Co. USD 25.39B 82M Sep/2025
Boston Scientific USD 22.65B 235M Sep/2025
Cooper Companies USD 8.35B 64.9M Jun/2025
Fresenius EUR 18.62B 320M Sep/2025
Fresenius Medical Care EUR 12.95B 1.38B Sep/2025
Globus Medical USD 4.4B 103.14M Sep/2025
Haemonetics USD 849.17M 33.13M Sep/2025
Hologic USD 5.25B 197.2M Dec/2025
ICU Medical USD 2.13B 11.47M Sep/2025
Intuitive Surgical USD 17.82B 894.3M Dec/2025
Masimo USD 810M 232.8M Sep/2025
Medtronic USD 47.89B 131M Jun/2025
Merit Medical Systems USD 1.53B 41.36M Sep/2025
Neogen USD 2.1B 14.16M Sep/2025
Quidel USD 2.04B 756.3M Sep/2025
ResMed USD 6.32B 199.61M Dec/2025
STAAR Surgical USD 353.78M 17.21M Sep/2025
Steris USD 7.01B 52.1M Sep/2025
Stryker USD 21.78B 594M Sep/2025
Teleflex USD 3.82B 421M Sep/2025
Terumo JPY 1.44T 68.46B Sep/2025
Thermo Fisher Scientific USD 53.54B 2.38B Dec/2025
US Physical Therapy USD 503.57M 2.82M Sep/2025
Zimmer Biomet Holdings USD 12.77B 231.7M Sep/2025